Dimitri E. Grigoriadis, Chief Research Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 17,364 shares at $105.44 ($1.8M) on 2020-05-07, disclosed to the SEC on 2020-05-11.
Open-market sale of $1.8M NBIX by Chief Research Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.44 | 8,682 | $915K | 50.0% |
| 2 | $105.44 | 8,682 | $915K | 50.0% |
| Total | $105.44 avg | 17,364 | $1.8M | 100% |
| Filing → |
| NBIX | SELL | 2020-11-16 | $410K | — | Filing → |
| NBIX | SELL | 2020-08-07 | $536K | — | Filing → |
| NBIX | SELL | 2020-05-20 | $10.8M | — | Filing → |